These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 16403919)

  • 21. Effect of glutamate receptor antagonists microinjected into the nucleus accumbens on place aversion induced by naloxone in single-dose, morphine-treated rats.
    Kawasaki Y; Ishida S; Jin C; Kitamura Y; Kawasaki H; Gomita Y; Sendo T; Araki H
    Eur J Pharmacol; 2011 Sep; 666(1-3):131-4. PubMed ID: 21635886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schedule-induced physical dependence on ethanol.
    Falk JL; Samson HH
    Pharmacol Rev; 1975 Dec; 27(4):449-64. PubMed ID: 772699
    [No Abstract]   [Full Text] [Related]  

  • 23. Short-term development of behavioral sensitization to amphetamine requires N-methyl-D-aspartate- and nicotinic-dependent mechanisms in the nucleus accumbens.
    Degoulet M; Rostain JC; Abraini JH; David HN
    Addict Biol; 2013 May; 18(3):417-24. PubMed ID: 21309959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergent anatomical pattern of D1 and D3 binding and dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa mRNA expression in the Roman rat strains: Implications for drug addiction.
    Guitart-Masip M; Johansson B; Fernández-Teruel A; Cañete T; Tobeña A; Terenius L; Giménez-Llort L
    Neuroscience; 2006 Nov; 142(4):1231-43. PubMed ID: 17008016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Synapse; 1998 Oct; 30(2):227-35. PubMed ID: 9723793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion.
    Kim JH; Vezina P
    J Pharmacol Exp Ther; 1998 Jan; 284(1):317-22. PubMed ID: 9435194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of drug dependence: use of a conditioned place preference paradigm].
    Funada M; Aoo N
    Nihon Yakurigaku Zasshi; 2007 Aug; 130(2):128-33. PubMed ID: 17690494
    [No Abstract]   [Full Text] [Related]  

  • 28. N-Acetylcysteine in Treatment of Substance Use Disorders.
    Gorelick DA
    Biol Psychiatry; 2019 Jun; 85(11):e59. PubMed ID: 30563762
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply to: N-Acetylcysteine in Treatment of Substance Use Disorders.
    Kalivas PW; Spencer S
    Biol Psychiatry; 2019 Jun; 85(11):e61. PubMed ID: 30563761
    [No Abstract]   [Full Text] [Related]  

  • 30. Examining the addictive-like properties of binge eating using an animal model of sugar dependence.
    Avena NM
    Exp Clin Psychopharmacol; 2007 Oct; 15(5):481-91. PubMed ID: 17924782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different function of pedunculopontine GABA and glutamate receptors in nucleus accumbens dopamine, pedunculopontine glutamate and operant discriminative behavior.
    Steiniger-Brach B; Kretschmer BD
    Eur J Neurosci; 2005 Oct; 22(7):1720-30. PubMed ID: 16197512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addiction and the problem of relapse.
    Harv Ment Health Lett; 2007 Jan; 23(7):4-7. PubMed ID: 17310529
    [No Abstract]   [Full Text] [Related]  

  • 33. Beating abuse. Glutamate may hold a key to drug addiction.
    Powledge TM
    Sci Am; 2002 Jan; 286(1):20. PubMed ID: 11799610
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel mouse brain slice preparation of the hippocampo-accumbens pathway.
    Matthews RT; Coker O; Winder DG
    J Neurosci Methods; 2004 Aug; 137(1):49-60. PubMed ID: 15196826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scientists seek cause of drug craving.
    Kuehn BM
    JAMA; 2006 Jan; 295(2):148-9. PubMed ID: 16403919
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.